Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Bullous Pemphigoid
NCT00525616Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Dec 2008
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in Bullous Pemphigoid (BP), sponsored by Rouen University Hospital. Started Dec 2008; status: completed.
02
Drugs
rituximab
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT00525616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525616.